Eyenuk Secures $26M in Series A Funding to Accelerate Global Access to AI-Based Eye Screening Technology
Eyenuk today announced that it has secured $26 million in a Series A funding round, bringing the company’s total funding to over $43 million. The capital raise was led by AXA IM Alts and was joined by new and existing investors including T&W Medical A/S, A&C Foelsgaard Alternativer ApS, Kendall Capital Partners and KOFA Healthcare. …